Alessandra Tucci | Personalized Medicine | Women Researcher Award

Alessandra Tucci | Personalized Medicine | Women Researcher Award

Dr. Alessandra Tucci, ASST Spedali Civili di Brescia, Italy

Dr. Alessandra Tucci is an esteemed Italian hematologist and Director of the Hematology Unit at ASST Spedali Civili di Brescia. With over three decades of expertise, she specializes in lymphomas, particularly in elderly patients. She holds dual specializations in Allergology & Immunology (University of Florence) and Hematology (University of Milan). A key figure in national and international research, she has led multiple clinical trials and serves on prestigious scientific boards, including the Italian Lymphoma Foundation (FIL) and European Hematology Association (EHA). An accomplished author and peer reviewer, Dr. Tucci continues to advance hematological research.

Publication Profile

Scopus

Education

Dr. Alessandra Tucci 🎓 earned her Doctor of Medicine degree from the University of Brescia in 1987, specializing in Allergology, Immunology, and Hematology. 🩸 Her dual specialization underscores her deep expertise in blood disorders and immune-related conditions. 🏥 Passionate about advancing medical science, she further pursued a Master’s in Management applied to hematology, showcasing her leadership in clinical and research settings. 📚 With a strong foundation in both patient care and scientific innovation, Dr. Tucci continues to make significant contributions to the field, bridging the gap between medical research and practical healthcare solutions. 🔬✨

Experience

Dr. Alessandra Tucci 🔬 is a Principal Investigator in numerous national and international studies, focusing on hematology, particularly lymphomas and hematologic malignancies in elderly patients. 🩸 Her research impact is evident through an impressive H-index of 44 (Scopus) and 48 (Google Scholar), with over 9,792 citations. 📊 She has contributed as a Guest Editor for Special Issues in high-impact journals like Cancers and serves as a reviewer for prestigious publications such as Lancet Haematology and Blood Advances. 📖 Her dedication to advancing hematologic research continues to shape the field and improve patient outcomes worldwide.

Awards

Dr. Alessandra Tucci 🏆 has played a pivotal role in clinical trials (phases I-III), driving innovative treatments in hematology and significantly improving patient care. 🩸 Her contributions extend beyond research, as she actively shapes the scientific community through editorial work, peer reviews, and participation in prestigious scientific boards. 📖🔬 Recognized for her expertise and leadership, she is a respected thought leader whose work influences both clinical practice and future therapeutic advancements. 🌍✨ Through her dedication, Dr. Tucci continues to leave a lasting impact on the field of hematology, inspiring researchers and improving patient outcomes worldwide. 💡👩‍⚕️

Research Focus

Dr. Alessandra Tucci is a distinguished researcher specializing in hematology 🩸, with a focus on lymphomas 🦠, leukemias 🧬, and stem cell transplantation 🏥. Her work extensively explores invasive pulmonary aspergillosis in leukemia, mantle cell lymphoma prognosis, and the impact of radiotherapy on hematologic malignancies. She contributes to clinical trials, geriatric oncology assessments, and advanced imaging techniques like FDG PET/CT 📡 to improve diagnostic precision and treatment outcomes. Dr. Tucci’s research plays a critical role in optimizing chemoimmunotherapy 💉 and personalized medicine for hematologic disorders.

Publication Top Notes

Different Epidemiology of Invasive Pulmonary Aspergillosis in Acute Lymphoblastic Leukemia in Comparison With Acute Myeloid Leukemia: Results of a Prospective Multicentric Observational Study of the Rete Ematologica Lombarda

Impact of the Number of Administered Systemic Treatment Lines on Local Response to Radiation Therapy for Multiple Myeloma

A phase 2 study of autologous stem cell transplantation as salvage therapy for older patients with aggressive B-cell lymphoma prospectively evaluated by comprehensive geriatric assessment: the FIL_RECANZ study

Prognostic Role of Pretreatment Tumor Burden and Dissemination Features From 2-[18F]FDG PET/CT in Advanced Mantle Cell Lymphoma

Early progression beyond first-line chemoimmunotherapy in follicular lymphoma: Insights from a Fondazione Italiana Linfoma (FIL) study

Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results

Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (Genome Medicine, (2023), 15, 1, (22), 10.1186/s13073-023-01173-8)

Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial
2-[18]F FDG PET/CT dissemination features in adult burkitt lymphoma Are predictive of outcome

Tiziana Russo Spena | Pharmaceutical Biotechnology | Best Paper Award

Tiziana Russo Spena | Pharmaceutical Biotechnology | Best Paper Award

Prof. Tiziana Russo Spena, Dipartimento di Economia management Istituzioni, Università degli Studi di Napoli Federico II, Italy

Prof. Tiziana Russo Spena is a Full Professor of Economics and Business Management at the University of Naples Federico II 🇮🇹. She holds a Ph.D. in Business Economics and specializes in digital health, sustainable business models, and stakeholder engagement 🔬💡. She has led multiple national and international research projects, including initiatives on blockchain in the agri-food sector, interactive robotics for aging well, and digital health services 🤖🌿. With extensive academic contributions, she plays a key role in shaping innovative business strategies and economic frameworks. 📚🏆

Publication Profile

Scopus

Education

Prof. Tiziana Russo Spena 🎓 is a distinguished Full Professor of Economics and Business Management (2022). She earned her Ph.D. in Business Economics (2002-2005) from the Faculty of Economics, University of Naples Federico II. Prior to that, she completed a Master’s in Investment Project Evaluation (2002) at the Research Centre of Urban and Territorial Management (L.U.P.T). Her academic journey began with a Degree in Business and Administration (1998), graduating with top honors (110/110 cum laude) from the same university. With a strong foundation in business and economics, she has made remarkable contributions to the field. 📚💼

Institutional And Membership

Prof. Tiziana Russo Spena 🎓 is an active member of the academic and research community, contributing to various institutional and membership activities. In 2024, she joined the Editorial Board of the International Journal of Research in Marketing and became the Coordinator of the Ph.D. Program in Management at the University of Naples Federico II. She serves as a board member of ReSER and CAISIAL, a treasurer at ReSER, and a key member of the Ateneo Commission for Internationalization. Additionally, she co-founded the Italian Blockchain National Observatory and leads advanced training courses in social media marketing and blockchain. 🔗📚

Awards

Prof. Tiziana Russo Spena 🏆 has received numerous prestigious awards for her research and contributions. In 2022, her article on COVID-19’s impact won the Highly Commended Paper award. She earned the Outstanding Paper Award (2013) for her work on store experience and co-creation. Her research on food innovation won the Best Paper Award (2013) at Lucerne University. Recognized as a Pioneer of Human Side of Service Engineering (2012), she was also a finalist in the Start Cup-Campania Competition (2011). Additionally, she received the Best Service Innovation Thinking Award (2008) and the Roberto Marrama Prize (2004). 🏅

Teaching Activities

Prof. Tiziana Russo Spena 🎓 has an extensive teaching career spanning various disciplines in business and management. Since 2019, she has been a Professor of Ethics and Management at the University of Naples Federico II. She also teaches Management (2018–present) and Marketing of Pharmaceutical Products (2012–present). Previously, she taught International Management (2013–2019), Retail Management (2013–2016), and International Marketing (2016–2018). She was a Visiting Professor in Brazil (2013) and an Assistant Professor at Magna Graecia University (1994–2012). Her contributions span agrifood, non-profits, and international trade, shaping future business leaders. 📚

Research Focus

Professor Tiziana Russo Spena specializes in service innovation, digital transformation, and customer experience, particularly in emerging digital ecosystems. Her research focuses on topics such as the phygital customer journey 🛍️📱, human-robot collaboration 🤖🤝, the metaverse in business and marketing 🌐🎭, and technology-enabled value co-creation 💡🔗. She explores how smart technologies and AI-driven solutions enhance consumer engagement and service management. Additionally, she investigates the role of innovation ecosystems in cultural heritage 🏛️📜. Her interdisciplinary approach integrates marketing, digital services, and technology management, shaping the future of service design and digital customer interactions.

Publication Top Notes

Unravelling the customer journey: A conceptual framework and research agenda

Phygital customer journey: a practice-based approach

A system and learning perspective on human–robot collaboration

Experimenting on the metaverse to foster innovation

HCAI-Based Service Provision for an Engaged University

Agencement of onlife and phygital: smart tech–enabled value co-creation practices

Innovative value propositions in the fashion metaverse

Addressing Socio-Material Issues for an Emerging Innovation Ecosystem: Insights From Cultural Heritage

Dr. Rahim Dehghan|Pharmaceutical Biotechnology| Best Researcher Award

Dr. Rahim Dehghan|Pharmaceutical Biotechnology |Best Researcher Award|

Dr. Rahim Dehghan at mus alparslan university, Turkeys

PROFILE  

scopus

Google Sholar

 

Early Academic Pursuits 🎓

Rahim Dehghan embarked on his academic journey in the field of polymer engineering at Shiraz University, where he earned his bachelor’s degree in 2011. Driven by a deep curiosity and passion for polymer science, he pursued a master’s degree in polymer engineering at Yazd University, completing it in 2015. His master’s thesis was a significant exploration of blood-compatible membranes, a topic that laid the foundation for his future research endeavors. This period of academic training provided him with a robust understanding of polymer materials and their applications in biomedical engineering, particularly in the development of membranes for medical use.

Professional Endeavors and Research Focus 🧪

Dehghan’s professional career has been marked by a series of research positions and projects that have focused on the development and enhancement of synthetic membranes for biomedical applications. In 2016, he commenced his Ph.D. at the prestigious Iran Polymer and Petrochemical Institute, a leading center for polymer education in Iran. His doctoral research was centered on developing membranes for the separation of low-density lipoprotein (LDL), commonly known as bad cholesterol, from blood plasma. This work was groundbreaking, as it addressed critical challenges in blood purification technologies, aiming to improve the efficiency and efficacy of these processes.

During his Ph.D. studies, Dehghan worked on several key aspects of membrane engineering, including pore size optimization, morphology control, and enhancing membrane permeability. His innovative approach to membrane structural engineering was aimed at achieving high-performance membranes capable of selective separation of LDL from blood plasma, while ensuring high plasma permeability. His research contributions during this period culminated in a Ph.D. degree, awarded in 2022 with an excellent grade, reflecting the significance and quality of his work.

Contributions and Research Focus 🌍

Dehghan’s research has had a profound impact on the field of membrane science, particularly in the development of membranes for biomedical applications. His work on LDL separation has opened new avenues for research in blood purification technologies, with potential applications in treating cardiovascular diseases and other conditions where blood purification is critical. He has also contributed to the field of microfiltration membranes for plasmapheresis, a process used to separate plasma from blood cells. His recent work has successfully developed a microfiltration membrane capable of simultaneously separating LDL and blood cells from whole blood, a significant advancement in this area.

In addition to his academic research, Dehghan has played a crucial role in the industrial application of his findings. As a researcher at the Iranian Polymer and Petrochemical Institute and a senior researcher at D.G.DENA Co., he has applied his expertise to the development of biomedical devices, including hydrogels and gels for wound care. His work in these roles has involved the application of advanced polymer science to address real-world challenges in medical device manufacturing.

Accolades and Recognition 🏆

Throughout his academic and professional career, Dehghan has received numerous accolades that highlight his contributions to the field of polymer engineering. One of his early achievements was acquiring the 8th rank in the national Ph.D. entrance exam in Iran in 2016, a highly competitive examination with over 400 participants. This accomplishment not only earned him a prestigious scientific award but also set the stage for his successful academic career.

His research has been widely recognized and published in several leading international journals, including the Journal of Membrane Science and Separation and Purification Technology. These publications have not only disseminated his findings to the broader scientific community but have also established him as a leading researcher in the field of polymer-based membrane technologies.

Impact and Influence 🌟

Dehghan’s work has had a significant impact on both the academic and industrial sectors. His research on membrane technologies has provided new insights into the design and development of high-performance membranes for medical applications. These contributions are particularly important in the context of blood purification technologies, where efficient and selective separation processes are critical for patient outcomes.

In the industrial sphere, his work as a consultant and researcher has directly influenced the development of new medical devices, particularly in the area of wound care. His expertise in polymer science has been instrumental in advancing the capabilities of these devices, ensuring they meet the stringent requirements of biomedical applications.

Legacy and Future Contributions 🌠

Looking ahead, Rahim Dehghan’s contributions to the field of polymer engineering and membrane science are poised to leave a lasting legacy. His work has already set new standards for the development of synthetic membranes, particularly in the biomedical field. As he continues to explore new research opportunities, particularly in the field of blood purification membranes such as hemodialysis and hemodiafiltration, his impact on the field is expected to grow.

🎓Publication 

Dextran sulfate bulk and surface-modified microfiltration membrane for simultaneous blood plasma harvesting and low-density lipoprotein removal during plasmapheresis

  • Authors   :Dehghan, R., Barzin, J., Carbonell, R.G., Ghaderi Jafarbeigloo, H., Kordkatooli, Z.
  • Journal    :Journal of Membrane Science
  • Year         :2024

Evaluation of solubility parameters and relative energy difference (RED) on the preparation of polysulfone/polyethylene glycol membrane: A study on the casting solution and coagulation bath

Membrane patterning through horizontally aligned microchannels developed by sulfated chopped carbon fiber for facile permeability of blood plasma components in low-density lipoprotein apheresis

High cut-off membrane: evaluation of pore collapse and the synergistic effect of low and high molecular weight polyvinylpyrrolidone

Low density lipoprotein (LDL) apheresis from blood plasma via anti-biofouling tuned membrane incorporated with graphene oxide-modified carrageenan